Miguel Reina-Campos

Miguel Reina-Campos

Auto-generated profile, based on publicly available information

Miguel Reina-Campos

La Jolla Institute for Immunology , La Jolla, CA 92037

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JMJ. Justin Milner
J. Justin Milner
HNHongtuyet Nguyen
Hongtuyet Nguyen
KOKyla Omilusik
Kyla Omilusik
MRMiguel Reina-Campos
Miguel Reina-Campos
MTMatthew Tsai
Matthew Tsai
AGAnanda W. Goldrath
Ananda W. Goldrath
Significance: Memory CD8 T lymphocytes are a long-lived population of immune cells that provide formidable protection against infections and malignancy and are thus often central to vaccine and cancer immunotherapy efficacy. Here we refine the identity, developmental relationships, and functional roles of memory CD8 T cells in mice through delineation of a discrete population that confers robust protection against reinfection and exhibits an unexpected molecular program bearing typically divergent characteristics of short-lived effector cells and long-lived memory T cells. Mass cytometry and single-cell RNA-sequencing analyses revealed an analogous population of cells in humans. These findings hold broad implications for both informing immunotherapy treatments and predicting their efficacy.

5 November 2019 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
MRMiguel Reina-Campos
Miguel Reina-Campos
MDMaria T. Diaz-Meco
Maria T. Diaz-Meco
JMJorge Moscat
Jorge Moscat
The serine glycine and one-carbon pathway (SGOCP) is a crucially important metabolic network for tumorigenesis, of unanticipated complexity, and with implications in the clinic. Solving how this network is regulated is key to understanding the underlying mechanisms of tumor heterogeneity and therapy resistance. Here, we review its role in cancer by focusing on key enzymes with tumor-promoting functions and important products of the SGOCP that are of physiological relevance for tumorigenesis. We discuss the regulatory mechanisms that coordinate the metabolic flux through the SGOCP and their deregulation, as well as how the actions of this metabolic network affect other cells in the tumor microenvironment, including endothelial and immune cells.

1 August 2018 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
MRMiguel Reina-Campos
Miguel Reina-Campos
PSPhillip M. Shelton
Phillip M. Shelton
MDMaria T. Diaz-Meco
Maria T. Diaz-Meco
JMJorge Moscat
Jorge Moscat

26 May 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JMJ. Justin Milner
J. Justin Milner
CTClara Toma
Clara Toma
SQSara Quon
Sara Quon
KOKyla Omilusik
Kyla Omilusik
NSNicole Scharping
Nicole Scharping
AGAnanda W. Goldrath
Ananda W. Goldrath
In response to infection, pathogen-specific CD8 T cells differentiate into functionally diverse effector and memory T cell populations critical for resolving disease and providing durable immunity. Through small-molecule inhibition, RNAi studies, and induced genetic deletion, we reveal an essential role for the chromatin modifier and BET family member BRD4 in supporting the differentiation and maintenance of terminally fated effector CD8 T cells during infection. BRD4 bound diverse regulatory regions critical to effector T cell differentiation and controlled transcriptional activity of terminal effector–specific super-enhancers in vivo. Consequentially, induced deletion of Brd4 or small molecule–mediated BET inhibition impaired maintenance of a terminal effector T cell phenotype. BRD4 was also required for terminal differentiation of CD8 T cells in the tumor microenvironment in murine models, which we show has implications for immunotherapies. Taken together, these data reveal an unappreciated requirement for BRD4 in coordinating activity of cis regulatory elements to control CD8 T cell fate and lineage stability.

13 December 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
YMYu Muta
Yu Muta
JLJuan F. Linares
Juan F. Linares
AMAnxo Martinez-OrdoñeZ
Anxo Martinez-OrdoñeZ
ADAngeles Duran
Angeles Duran
TCTania Cid-Diaz
Tania Cid-Diaz
JMJorge Moscat
Jorge Moscat
The metabolic and signaling pathways regulating aggressive mesenchymal colorectal cancer (CRC) initiation and progression through the serrated route are largely unknown. Although relatively well characterized as BRAF mutant cancers, their poor response to current targeted therapy, difficult preneoplastic detection, and challenging endoscopic resection make the identification of their metabolic requirements a priority. Here, we demonstrate that the phosphorylation of SCAP by the atypical PKC (aPKC), PKCλ/ι promotes its degradation and inhibits the processing and activation of SREBP2, the master regulator of cholesterol biosynthesis. We show that the upregulation of SREBP2 and cholesterol by reduced aPKC levels is essential for controlling metaplasia and generating the most aggressive cell subpopulation in serrated tumors in mice and humans. Since these alterations are also detected prior to neoplastic transformation, together with the sensitivity of these tumors to cholesterol metabolism inhibitors, our data indicate that targeting cholesterol biosynthesis is a potential mechanism for serrated chemoprevention.

22 January 2025 in Journal of Experimental Medicine
Verified
Journal Article
Closed access
AFAmir Ferry
Amir Ferry
KMKianoosh M. Mempel
Kianoosh M. Mempel
AMAlexander Monell
Alexander Monell
MRMiguel Reina-Campos
Miguel Reina-Campos
NSNicole Scharping
Nicole Scharping
AGAnanda W. Goldrath
Ananda W. Goldrath
Tissue-resident memory T cells (TRM) provide frontline protection against pathogens and emerging malignancies. Tumor-infiltrating lymphocytes (TIL) with TRM features are associated with improved clinical outcomes. However, the cellular interactions that program TRM differentiation and function are not well understood. Using murine genetic models and targeted spatial transcriptomics, we found that the CD8+ T cell–derived chemokine XCL1 is critical for TRM formation and conventional DC1 (cDC1) supported the positioning of intestinal CD8+ T cells during acute viral infection. In tumors, enforced Xcl1 expression by antigen-specific CD8+ T cells promoted intratumoral cDC1 accumulation and T cell persistence, leading to improved overall survival. Notably, analysis of human TIL and TRM revealed conserved expression of XCL1 and XCL2. Thus, we have shown that the XCL1–XCR1 axis plays a non-cell autonomous role in guiding intestinal CD8+ TRM spatial differentiation and tumor control.